Browse All

Current Filters

CLEAR FILTER x

TITLE

Impact of AXS-12 on Symptom Severity and Functional Impairment in Narcolepsy: Results From the Phase Three SYMPHONY Trial

Author:Thorpy, Michael   Krahn, Lois   Bogan, Richard   Corser, Bruce   Shapiro, Colin   Chen, Dan   Chhabra, Angad   Leary, Eileen   Tabuteau, Herriot   

Session Name:S3: Research Advances in Sleep and Clinical Impact  

Topic:Sleep  

Program Number:S3.008  

Author Institution:Montefiore Medical Center, Sleep-Wake Disorders Center, Bronx, NY  Mayo Clinic College of Medicine, Phoenix, AZ  Medical University of South Carolina, Charleston, SC  Intrepid Research, Cincinatti, OH  University of Toronto, Toronto, ON, Canada  Axsome Therapeutics, Inc., New York, NY  Formerly of Axsome Therapeutics, Inc., San Francisco, CA  

E2086, a Selective Orexin Receptor Two Agonist: Study for Promoting Wakefulness in Patients With Narcolepsy Type One

Author:Corser, Bruce   Cheng, Jocelyn   Hall, Nancy   Rawal, Sumit   Moline, Margaret   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.003  

Author Institution:Sleep Management Institute, OH  Eisai Inc., Nutley, NJ  

ENCORE: Topline Results of a Phase Three Open-label Extension and Randomized-withdrawal Trial of AXS-12 in Narcolepsy

Author:Bogan, Richard   Thorpy, Michael   Krahn, Lois   Corser, Bruce   Shapiro, Colin   Chen, Dan   Chhabra, Angad   Leary, Eileen   Tabuteau, Herriot   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.006  

Author Institution:Medical University of South Carolina, Charleston, SC  Montefiore Medical Center, Sleep-Wake Disorders Center, Bronx, NY  Mayo Clinic College of Medicine, Phoenix, AZ  Intrepid Research, Cincinatti, OH  University of Toronto, Toronto, ON, Canada  Axsome Therapeutics, Inc., New York, NY  Formerly of Axsome Therapeutics, Inc., San Francisco, CA